PROHANCE - LIQ IV 279.3MG/ML

Search images on Google      Product Monograph

Active Ingredients:

DIN: 02229056

Dosage Form(s): SOLUTION

Route(s) of Administration: INTRAVENOUS

Schedule: Ethical

Company: BRACCO IMAGING CANADA

ATC:

Reference brand drug: Prohance

Packaging:

  • Package size unit: No information
  • Package type: No information
  • Package size: No information
  • Product information: 10/15/17/20/50ML

Pharmaceutical standard: USP

 

External Links for Prohance - Liq Iv 279.3Mg/Ml:

Search on Google